Neural circuits mediating stress

Biological Psychiatry

Volumn 46, Issue 11, 1999, Pages 1461-1471

  López, Juan F ^a   Akil, Huda ^a   Watson, Stanley J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

ACTH; Adrenal; Glucocorticoids; Hypothalamus; Limbic; Stress

Indexed keywords

CORTICOSTEROID RECEPTOR; CORTICOTROPIN; GLUCOCORTICOID; NEUROTRANSMITTER; SEROTONIN;

AFFECTIVE NEUROSIS; ANXIETY NEUROSIS; BRAIN REGION; CONFERENCE PAPER; CONTROL SYSTEM; DEPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC SYSTEM; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; STRESS;

BRAIN; CHILD; CHILD DEVELOPMENT; HUMANS; NERVE NET; STRESS, PSYCHOLOGICAL;

EID: 0038160550     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00266-8     Document Type: Conference Paper

References (93)

1. Acs Z., Stark E. Possible role of gamma-aminobutyric acid synthesis in the mechanism of dexamethasone feedback inhibition. J Endocrinol. 77:1978;137-141.
2. Arango V., Underwood M., Mann J.J. Postmortem findings in suicide victims Implications for in vivo imaging studies . Ann NY Acad Sci. 836:1997;269-287.
3. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688:1995;121-133.
4. Barden N. Regulation of corticosteroid receptor gene expression in depression and antidepressant action. J Psychiatry Neurosci. 24:1999;25-39.
5. Brady L.S., Whitfield H.J. Jr, Fox R.J., Gold P.W., Herkenham M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J Clin Invest. 87:1991;831-837.
6. Breslau N., Davis G.C., Peterson E.L., Schultz L. Psychiatric sequelae of posttraumatic stress disorder in women. Arch Gen Psychiatry. 54:1997;81-87.
7. Brown E.R., Sawchenko P.E. Hypophysiotropic CRF neurons display a sustained immediate-early gene response to chronic stress but not adrenalectomy. J Neuroendocrinol. 9:1997;307-316.
8. Brown G.W. Life events and affective disorder Replications and limitations . Psychosom Med. 55:1993;248-259.
9. Brown G.W., Harris T.O., Eales M.J. Social factors and comorbidity of depressive and anxiety disorders. Br J Psychiatry. 30:1996;50-57.
10. Campeau S., Watson S.J. Neuroendocrine and behavioral responses and brain pattern of c-fos induction associated with audiogenic stress. J Neuroendocrinol. 9:1997;577-588.
11. Chalmers D.T., López J.F., Akil H., Watson S.J. Molecular aspects of the stress axis and serotonergic function in depression. Clin Neurosci. 1:1993;122-128.
12. Chalmers D.T., López J.F., Vázquez D.M., Akil H., Watson S.J. Regulation of hippocampal 5-HT1A receptor gene expression by dexamethasone. Neuropsychopharmacology. 10:1994;215-222.
13. Chalmers D.T., Lovenberg T.W., Grigoriadis D.E., Behan D.P., De Souza E.B. Corticotrophin-releasing factor receptors From molecular biology to drug design . Trends Pharmacol Sci. 17:1996;166-172.
14. Charney D.S., Deutch A. A functional neuroanatomy of anxiety and fear Implications for the pathophysiology and treatment of anxiety disorders . Crit Rev Neurobiol. 10:1996;419-446.
15. Coplan J.D., Lydiard R.B. Brain circuits in panic disorder. Biol Psychiatry. 44:1998;1264-1276.
16. Cullinan W.E., Helmreich D.L., Watson S.J. Fos expression in forebrain afferents to the hypothalamic paraventricular nucleus following swim stress. J Comp Neurol. 368:1996;88-99.
17. Cullinan W.E., Herman J.P., Battaglia D.F., Akil H., Watson S.J. Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience. 64:1995;477-505.
18. Cullinan W.E., Herman J.P., Watson S.J. Ventral subicular interaction with the hypothalamic paraventricular nucleus Evidence for a relay in the bed nucleus of the stria terminalis . J Comp Neurol. 332:1993;1-20.
19. Dallman M.F., Akana S.F., Cascio C.S., Darlington D.N., Jacobson L., Levin N. Regulation of ACTH secretion Variations on a theme of B . Recent Prog Horm Res. 43:1987;113-173.
20. Davidson J.R.T. Biological therapies for post-traumatic stress disorders An overview . J Clin Psychiatry. 58:1997;29-32.
21. Davis M.E. Are different parts of the extended amygdala involved in fear versus anxiety? Biol Psychiatry. 44:1998;1239-1247.
22. Decavel C., van den Pol A.N. Converging GABA- and glutamate-immunoreactive axons make synaptic contact with identified hypothalamic neurosecretory neurons. J Comp Neurol. 316:1992;104-116.
23. de Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M.J. Brain corticosteroid receptor balance in health and disease. Endocrine Rev. 19:1998;269-301.
24. Den Boer J.A. Pharmacotherapy of panic disorder Differential efficacy from a clinical viewpoint . J Clin Psychiatry. 59:1998;30-36.
25. Dorovini-Zis K., Zis A.P. Increased adrenal weight in victims of violent suicide. Endocrinology. 144:1987;1214-1215.
26. Ferraguti F., Zoli M., Aronsson M., Agnati L.F., Goldstein M., Filer D., Fuxe K. Distribution of glutamic acid decarboxylase messenger RNA-containing nerve cell populations of the male rat brain. J Chem Neuroanatomy. 3:1990;377-396.
27. Frank E., Anderson B., Reynolds C.F., Ritenour A., Kupfer D.J. Life events and the research diagnostic criteria endogenous subtype. A confirmation of the distinction using the Bedford College methods. Arch Gen Psychiatry. 51:1994;519-524.
28. Frohman L.A. Clinical neuropharmacology of hypothalamic releasing factors. N Engl J Med. 286:1972;1391-1397.
29. Fuller R.W. Serotonergic stimulation of pituitary-adrenocortical function in rats. Neuroendocrinology. 32:1981;118-127.
30. Fuller R.W. The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neuroendocrinol. 13:1992;250-270.
31. Fuller R.W., Snoddy H.D. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists. Neuroendocrinology. 52:1990;206-211.
32. Funder J.W. Adrenocorticoid receptors in the brain. Ganong W.F., Martini L. Frontiers in Neuroendocrinology. 1986;169-189 Raven Press, New York.
33. Fuxe K., Okret A.C., Agnati L.F., Harfstrand A., Yu Z.Y., Granholm L., et al. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptors. Endocrinology. 117:1985;1803-1812.
34. Gray T.S. Amygdaloid CRF pathways role in autonomic, neuroendocrine, and behavioral responses to stress. Ann NY Acad Sci. 697:1993;53-60.
35. Herman J.P., Adams D., Prewitt C. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology. 61:1995;180-190.
36. Herman J.P., Cullinan W.E. Neurocircuitry of stress Central control of the hypothalamo-pituitary-adrenocortical axis . Trends Neurosci. 20:1997;78-84.
37. Herman J.P., Cullinan W.E., Watson S.J. Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression. J Neuroendocrinol. 6:1994;433-442.
38. Herman J.P., Cullinan W.E., Young E.A., Akil H., Watson S.J. Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression. Brain Res. 592:1992;228-238.
39. Herman J.P., Prewitt C.M.-F., Cullinan W.E. Neuronal circuit regulation of the hypothalamic-pituitary-adrenocortical stress axis. Crit Rev Neurobiol. 10:1996;371-394.
40. Herman J.P., Schafer M.K.H., Sladek C.D., Day R., Young E.A., Akil H., Watson S.J. Chronic electroconvulsive shock treatment elicits up-regulation of CRF and AVP mRNA in select populations of neuroendocrine neurons. Brain Res. 501:1989;235-246.
41. Herman J.P., Schafer M.K.H., Young E.A., Thompson R., Douglass J., Akil H., Watson S.J. Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci. 9:1989;3072-3082.
42. Heuser I. The hypothalamic-pituitary-adrenalsystem in depression. Pharmacopsychiatry. 31:1998;10-13.
43. Hillhouse E.W., Milton N.G. Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. J Neuroendocrinol. 122:1989;713-718.
44. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev. 17:1996;187-205.
45. Jaeckle R.S., López J.F. Corticotropin releasing hormone Clinical endocrinology and implications for Cushing's disease and endogenous depression . Psycholo Med. 3:1986;111-134.
46. Keller-Wood M.E., Dallman M.F. Corticosteroid inhibition of ACTH secretion. Endocr Rev. 5:1984;1-23.
47. Kendler K.S., Karkowski L.M., Prescott C.A. Stressful life events and major depression Risk period, long-term contextual threat, and diagnostic specificity . J Nerv Ment Dis. 186:1998;661-669.
48. Kendler K.S., Neale M.D., Kessler R.C., Heath A.C., Eaves L.J. Childhood parental loss and adult psychopathology in women A twin study perspective . Arch Gen Psychiatry. 49:1992;109-116.
49. Kessler R.C., Davis C.G., Kendler K.S. Childhood adversity and adult psychiatric disorder in the US National Comorbidity Survey. Psycholo Med. 27:1997;1101-1119.
50. Kuroda Y., Mikuni M., Nomura N., Takahashi K. Differential effect of subchronic dexamethasone treatment on serotonin-2 and beta-adrenergic receptors in the rat cerebral cortex and hippocampus. Neurosci Lett. 155:1993;195-198.
51. Kuroda Y., Watanabe Y., Albeck D.S., Hastings N.B., McEwen B.S. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on 5-HT1A and 5-HT2 receptor binding and 5-HT transporter mRNA expression in rat brain. Brain Res. 648:1994;157-161.
52. LeDoux J. Fear and the brain Where have we been, and where are we going? Biol Psychiatry. 44:1998;1229-1238.
53. Leonard H.L. New developments in the treatment of obsessive-compulsive disorder. J Clin Psychiatry. 58:1997;39-45.
54. Levine S., Ursin H. What is stress? Brown M.R., Koob G.F., Rivier C. Stress, Neurobiology and Neuroendocrinology. 1991;1-21 Marcel Dekker, New York.
55. Li H.Y., Ericsson A., Sawchenko P.E. Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci USA. 93:1996;2359-2364.
56. Li H.Y., Sawchenko P.E. Hypothalamic effector neurons and extended circuitries activated in "neurogenic" stress A comparison of footshock effects exerted acutely, chronically, and in animals with controlled glucocorticoid levels . J Comp Neurol. 393:1998;244-266.
57. Liberzon I., Krstov M., Young E.A. Stress-restress Effects on ACTH and fast feedback . Psychoneuroendocrinology. 22:1997;443-453.
58. Liberzon I., López J.F., Flagel S.B., Vázquez D.M., Young E.A. Differential regulation of hippocampal glucocorticoid receptors mRNA and fast feedback Relevance to post-traumatic stress disorder . J Neuroendocrinol. 11:1999;11-17.
59. Linthorst A.C., Flachskamm C., Hopkins S.J., Hoadley M.E., Labeur M.S., Holsboer F., Reul J.M. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J Neurosci. 17:1997;448-4460.
60. López J.F., Vázquez D.M., Chalmers D.T., Watson S.J. Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis Implications for the neurobiology of suicide . Ann NY Acad Sci. 386:1997;106-134.
61. López J.F., Chalmers D.T., Little K.Y., Watson S.J. Regulation of 5HT1a receptor, glucocorticoid and mineralocorticoid receptor in rat and human hippocampus Implications for the neurobiology of depression . Biol Psychiatry. 43:1998;547-573.
62. López J.F., Palkovits M., Arato M., Mansour A., Akil H., Watson S.J. Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology. 56:1992;491-501.
63. López J.F., Vázquez D.M., Akil H., Watson S.J. Effect of imipramine administration and swim stress on the hypothalamic pituitary adrenal axis. Endocrine. 2:1994;723-728.
64. López J.F., Young E.A., Herman J.P., Akil H., Watson S.J. Regulatory Biology of the HPA Axis An Integrative Approach . 1991;American Psychiatric Press, Inc, Washington DC.
65. McEwen B.S., Wallach G., Magnus C. Corticosterone binding to hippocampus Immediate and delayed influences of the absence of adrenal secretion . Brain Res. 70:1974;321-334.
66. McKittrick C.R., Blanchard D.C., Blanchard R.J., McEwen B.S., Sakai R.R. Serotonin receptor binding in a colony model of chronic social stress. Biol Psychiatry. 37:1995;383-396.
67. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression New findings and new directions . Mol Psychiatry. 1:1996;336-342.
68. Nemeroff C.B. The neurobiology of depression. Sci Am. 278:1998;42-49.
69. Nemeroff C.B., Owens M.J., Bissette G., Andorn A.C., Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry. 45:1988;577-579.
70. Newman S.C., Bland R.C. Life events and the 1-year prevalence of major depressive episode, generalized anxiety disorder, and panic disorder in a community sample. Comp Psychiatry. 35:1994;76-82.
71. Pazos A., Palacios J.M. Quantitative autoradiographic mappin of serotonin receptors in the rat brain, I. Serotonin-1 receptors. Brain Res. 346:1985;205-230.
72. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain - III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience. 21:1987;97-122.
73. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain - IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience. 21:1987;123-139.
74. Plotsky P.M., Otto S., Sutton S. Neurotransmitter modulation of corticotropin releasing factor secretion into the hypophysial-portal circulation. Life Sci. 41:1987;1311-1317.
75. Post R.M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 149:1992;999-1010.
76. Price M.L., Curtis A.L., Kirby L.G., Valentino R.J., Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology. 18:1998;492-502.
77. Raadsheer F.C., Hoogendijk W.J., Stam F.C., Tilders F.J., Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 60:1994;436-444.
78. Raadsheer F.C., van Heerikhuize J.J., Lucassen P.J., Hoogendijk W.J., Tilders F.J., Swaab D.F. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry. 152:1995;1372-1376.
79. Reul J.M.H.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain Microdistribution and differential occupation . Endocrinology. 117:1985;2505-2511.
80. Reul J.M.H.M., Soder M., Holsboer F. The hypothalamic-pituitary-adrenocortical (HPA) system and anti-depressive drug (AD) action. Clin Neuropharmacol. 1:(Suppl 15):1992;584A-585A.
81. Seckl J.R., Dickson K.L., Fink G. Central 5, 7-dihydroxytryptamine lesions decrease hippocampal glucocortoid and mineralocorticoid receptor messenger ribonucleic acid expression. Neuroendocrinol. 2:1990;911-916.
82. Selye H. A syndrome produced by diverse nocious agents. Nature. 138:1936;32.
83. Selye H. The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol Metab. 6:1946;117-230.
84. Shiomi H., Watson S.J., Kelsey J., Akil H. Pretranslational and posttranslational mechanisms for regulating beta-endorphin/ACTH cells Studies in anterior lobe . Endocrinology. 119:1986;1793-1799.
85. Swanson L.W., Sawchenko P.E., Lind R.W. Regulation of multiple peptides in CRF parvocellular neurosecretory neurons Implications for the stress response . Prog Brain Res. 68:1986;169-190.
86. Szafarczyk A., Alonso G., Ixart G., Malaval F., Nougier-Soule Assenmacher I. Serotonin system and circadian rhythms of ACTH and corticosterone in rats. Am J Physiol. 239:1980;E482-E489.
87. Tollefson G.D. Selective serotonin reuptake inhibitors. Schatzberg A.F., Nemeroff C.B. Textbook of Psychopharmacology. 1995;161-182 American Psychiatric Press, Washington, DC.
88. Tork I. Anatomy of the serotonergic system. Ann NY Acad Sci. 600:1990;9-35.
89. Tork I, Hornung JP (1990): Raphe nuclei and the serotonergic system. The Human Nervous System. San Diego, CA: Academic Press.
90. Walaas I., Fonnum F. Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain. Neurosci. 5:1980;1691-1698.
91. Waterhouse B.D., Mihailoff G.A., Baack J.C., Woodward D.J. Topographical distribution of dorsal and median raphe neurons projecting to motor, sensorimotor, and visual cortical areas in the rat. J Comp Neurol. 249:1986;460-476.
92. Webster E., Lewis D., Torpy D., Zachman E., Rice K., Chrousos G.P. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist Suppression of pituitary ACTH release and peripheral inflammation . Endocrinology. 137:1996;5747-5750.
93. Young E.A., Haskett R.F., Murphy-Weinberg V., Watson S.J., Akil H. Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry. 48:1991;693-699.